The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia
Cunha F.Q., Poole S., Lorenzetti B.B., Ferreira S.H. (1992) The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol;107:660-664.
Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha
Woolf C.J., Allchorne A., Safieh-Garabedian B., Poole S. (1997) Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha. Br J Pharmacol;121:417-424.
Upregulation and interaction of TNF alpha and gelatinases A and B in painful peripheral nerve injury
Shubayev V.I., Myers R.R. (2000) Upregulation and interaction of TNF alpha and gelatinases A and B in painful peripheral nerve injury. Brain Res;855:83-89.
Minocycline prevents the development of neuropathic pain, but not acute pain: possible anti-inflammatory and antioxidant mechanisms
Padi S.S.V., Kulkarni S.K. (2008) Minocycline prevents the development of neuropathic pain, but not acute pain: possible anti-inflammatory and antioxidant mechanisms. Eur J Pharmacol;601:79-87.
Role of oxidative stress in pathophysiology of peripheral neuropathy and modulation by N-acetyl-l-cysteine in rats
Naik A.K., Tandan S.K., Dudhgaonkar S.P., Jadhav S.H., Kataria M., Prakash V.R., Kumar D. (2006) Role of oxidative stress in pathophysiology of peripheral neuropathy and modulation by N-acetyl-l-cysteine in rats. Eur J Pain;10:573-579.
Local expression of inducible nitric oxide synthase in an animal model of neuropathic pain
Levy D., Hoke A., Zochodne D.W. (1999) Local expression of inducible nitric oxide synthase in an animal model of neuropathic pain. Neurosci Lett;260:207-209.
The effect of thalidomide treatment on vascular pathology and hyperalgesia caused by chronic constriction injury of rat nerve
Sommer C., Marziniak M., Myers R.R. (1998) The effect of thalidomide treatment on vascular pathology and hyperalgesia caused by chronic constriction injury of rat nerve. Pain;74:83-91.
Anti-TNF-neutralizing antibodies reduce pain-related behavior in two different mouse models of painful mononeuropathy
Sommer C., Lindenlaub T., Teuteberg P., Schäfers M., Hartung T., Toyka K.V. (2001) Anti-TNF-neutralizing antibodies reduce pain-related behavior in two different mouse models of painful mononeuropathy. Brain Res;913:86-89.
Antituberculosis agents. I. Alpha-(5-(2-Furyl)-1,2,4-triazol-3-ylthio) acethydrazide and related compounds
Mir I., Siddiqui M.T., Comrie A. (1970) Antituberculosis agents. I. Alpha-(5-(2-Furyl)-1, 2, 4-triazol-3-ylthio) acethydrazide and related compounds. Tetrahedron;26:5235-5238.
Synthesis and biological activity of new derivatives of 3-(3,4-diaryl-1,2,4-triazole-5-yl)propenoic acid
Modzelewska-Banachiewicz B., Banachiewicz J., Chodkowska A., Jagiełło-Wójtowicz E., Mazur L. (2004) Synthesis and biological activity of new derivatives of 3-(3, 4-diaryl-1, 2, 4-triazole-5-yl)propenoic acid. Eur J Med Chem;39:873-877.
Synthesis of some 1,2,4-triazolo[3,2-b]-1,3-thiazine-7-ones with potential analgesic and antiinflammatory activities
Tozkoparan B., Aktay G., Yesilada E. (2002) Synthesis of some 1, 2, 4-triazolo[3, 2-b]-1, 3-thiazine-7-ones with potential analgesic and antiinflammatory activities. Farmaco;57:145-152.
Design, synthesis, and biological evaluation of substituted 3-alkylthio-4,5-diaryl-4H-1,2,4-triazoles as selective COX-2 inhibitors
Navidpour L., Shafaroodi H., Abdi K., Amini M., Ghahremani M.H., Dehpour A.R., Shafiee A. (2006) Design, synthesis, and biological evaluation of substituted 3-alkylthio-4, 5-diaryl-4H-1, 2, 4-triazoles as selective COX-2 inhibitors. Bioorg Med Chem;14:2507-2517.
Cyclization of the semicarbazone template of aryl semicarbazones: synthesis and anticonvulsant activity of 4,5-diphenyl-2H-1,2,4-triazol-3(4H)-one
Shalini M., Yogeeswari P., Sriram D., Stables J.P. (2009) Cyclization of the semicarbazone template of aryl semicarbazones: synthesis and anticonvulsant activity of 4, 5-diphenyl-2H-1, 2, 4-triazol-3(4H)-one. Biomed Pharmacother;63:187-193.
1,2,4-Triazole derivatives as sigma receptor inhibitors. European Patent 1,921,073.
Alberto D.Z., Nadine J., Maria Pillar G.J., Maria Rosa C.A., Jose C.M. 1, 2, 4-Triazole derivatives as sigma receptor inhibitors. European Patent 1, 921, 073.
Discovery of 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1h-1,2,4-triazole, a novel in vivo cannabinoid antagonist containing a 1,2,4-triazole motif
Jagerovic N., Hernandez-Folgado L., Alkorta I., Goya P., Navarro M., Serrano A., de Fonseca F.R., Dannert M.T., Alsasua A., Suardiaz M., Pascual D., Martin M.I. (2004) Discovery of 5-(4-chlorophenyl)-1-(2, 4-dichlorophenyl)-3-hexyl-1h-1, 2, 4-triazole, a novel in vivo cannabinoid antagonist containing a 1, 2, 4-triazole motif. J Med Chem;47:2939-2942.
Bioisosteric replacements of the pyrazole moiety of rimonabant: synthesis, biological properties, and molecular modeling investigations of thiazoles, triazoles, and imidazoles as potent and selective CB1 cannabinoid receptor antagonists
Lange J.H., van Stuivenberg H.H., Coolen H.K., Adolfs T.J., McCreary A.C., Keizer H.G., Wals H.C., Veerman W., Borst A.J., de Looff W., Verveer P.C., Kruse C.G. (2005) Bioisosteric replacements of the pyrazole moiety of rimonabant: synthesis, biological properties, and molecular modeling investigations of thiazoles, triazoles, and imidazoles as potent and selective CB1 cannabinoid receptor antagonists. J Med Chem;48:1823-1838.
A note on a simple apparatus for detecting neurological deficit in rats and mice
Dunham N.W., Miya T.S. (1957) A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc Am Pharm Assoc (Baltim);46:208-209.
A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury
Seltzer Z., Dubner R., Shir Y. (1990) A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain;43:205-218.
Pharmacological characterisation of a rat model of incisional pain
Garth T., Whiteside J.H., Jamie B., Lilly M., Michelle P., Susan G., Katharine W. (2004) Pharmacological characterisation of a rat model of incisional pain. Br J Pharmacol;141:85-91.
Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammation
Sekut L., Yarnall D., Stimpson S.A., Noel L.S., Bateman-Fite R., Clark R.L., Brackeen M.F., Menius J.A. Jr, Connolly K.A. (1995) Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammation. Clin Exp Immunol;100:126-132.
Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain
Choi Y., Yoon Y.W., Na H.S., Kim S.H., Chung J.M. (1994) Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain. Pain;59:369-376.
The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury
Coderre T.J., Melzack R.J. (1992) The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury. J Neurosci;12:3665-3670.
Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat
Chaplan S.R., Malmberg A.B., Yaksh T.L. (1997) Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat. J Pharmacol Exp Ther;280:829-838.
Characterization of nociceptive responses and spinal releases of nitric oxide metabolites and glutamate evoked by different concentrations of formalin in rats
Okuda K., Sakurada C., Takahashi M., Yamada T., Sakurada T. (2001) Characterization of nociceptive responses and spinal releases of nitric oxide metabolites and glutamate evoked by different concentrations of formalin in rats. Pain;92:107-115.
Plant derived alkaloid (-)-cassine induces anti-inflammatory and anti-hyperalgesics effects in both acute and chronic inflammatory and neuropathic pain models
da Silva K.A., Manjavachi M.N., Paszcuk A.F., Pivatto M., Viegas C. Jr, Bolzani V.S., Calixto J.B. (2011) Plant derived alkaloid (-)-cassine induces anti-inflammatory and anti-hyperalgesics effects in both acute and chronic inflammatory and neuropathic pain models. Neuropharmacology;62:967-977.
